Sunday, 9 August, 2020, 9:06 PM
latest Noted music director Alauddin Ali passes away       Major Sinha's killers will get severe punishment: Hanif       Major Sinha dies of profuse bleeding as 3 bullets pierce his body: Autopsy report       34 virus deaths reported in last 24hrs in country      
Home International

WHO sees first results from COVID drug trials within two weeks

Published : Saturday, 4 July, 2020 at 12:40 AM  Count : 466
Observer Online News Desk

WHO sees first results from COVID drug trials within two weeks
GENEVA/LONDON: The World Health Organization (WHO) should soon get results from clinical trials it is conducting of drugs that might be effective in treating COVID-19 patients, its Director General Tedros Adhanom Ghebreyesus said on Friday.

"Nearly 5,500 patients in 39 countries have so far been recruited into the Solidarity trial," he told a news briefing, referring to clinical studies the UN agency is conducting.

"We expect interim results within the next two weeks."

The Solidarity Trial started out in five parts looking at possible treatment approaches to COVID-19: standard care; remdesivir; the anti-malaria drug touted by US President Donald Trump, hydroxychloroquine; the HIV drugs lopinavir/ritonavir; and lopanivir/ritonavir combined with interferon.

Earlier this month, it stopped the arm testing hydroxychloroquine, after studies indicated it showed no benefit in those who have the disease, but more work is still needed to see whether it may be effective as a preventative medicine.

Mike Ryan, head of the WHO’s emergencies program, said it would be unwise to predict when a vaccine could be ready against COVID-19, the respiratory disease caused by the novel coronavirus that has killed more than half a million people.
While a vaccine candidate might show its effectiveness by year’s end, the question was how soon it could be mass produced, he told the UN journalists’ association ACANU in Geneva.

There is no proven vaccine against the disease now, while 18 potential candidates are being tested on humans.
WHO officials defended their response to the virus that emerged in China last year, saying they had been driven by the science as it developed. Ryan said what he regretted was that global supply chains had broken, depriving medical staff of protective equipment.

"I regret that there wasn’t fair, accessible access to COVID tools. I regret that some countries had more than others, and I regret that front-line workers died because of (that)," he said.





He urged countries to get on with identifying new clusters of cases, tracking down infected people and isolating them to help break the transmission chain.

"People who sit around coffee tables and speculate and talk (about transmission) don't achieve anything. People who go after the virus achieve things," he said.

AGENCIES/SZA

Related Topics

WHO sees first results   COVID drug trials  




« PreviousNext »



Latest News
Most Read News
Editor : Iqbal Sobhan Chowdhury
Published by the Editor on behalf of the Observer Ltd. from Globe Printers, 24/A, New Eskaton Road, Ramna, Dhaka.
Editorial, News and Commercial Offices : Aziz Bhaban (2nd floor), 93, Motijheel C/A, Dhaka-1000. Phone: PABX 9586651-58; Online: 9513959; Advertisement: 9513663
E-mail: [email protected], [email protected], [email protected], [email protected],   [ABOUT US]     [CONTACT US]   [AD RATE]   Developed & Maintenance by i2soft